Symmetry Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Symmetry Partners's AMGN Position: Q3 2024 in Review
Symmetry Partners sold out of Amgen (AMGN) in Q3 2024, closing a stake of 3,436 shares — an estimated $1.07M sold.
Symmetry Partners first reported a position in AMGN in Q4 2018 and held it in 22 quarters. The position peaked at $3.17M in Q4 2022. 2,824 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.
- Symmetry Partners reported no remaining Amgen position as of Q3 2024 after selling out during the quarter.
- Symmetry Partners sold 3,436 Amgen shares in Q3 2024, an estimated $1.07M.
- Symmetry Partners first reported a position in Amgen in Q4 2018 and held it in 22 quarters.
- Symmetry Partners's Amgen position peaked at $3.17M in Q4 2022.
- 2,824 funds tracked by Wall St. Rank held Amgen as of Q3 2024.
Based on Symmetry Partners's 13F filing for Q3 2024, filed 29 Oct 2024.